Form 4: ReposiTrak CEO Randall Fields Sells Shares to Meet Charitable Commitments
SEC Form 4 Filing
ReposiTrak's CEO, Randall K. Fields, executed sales of common stock on February 10th and 11th, 2025, to fulfill charitable pledges through a pre-established Rule 10b5-1 trading plan.
Summary
- Randall K. Fields, CEO of ReposiTrak, Inc. (TRAK), reported the sale of company stock on February 10th and 11th, 2025.
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan.
- On February 10th, 5,000 shares of common stock were sold at a weighted average price of $20.8466, with individual prices ranging from $20.75 to $20.97.
- On February 11th, an additional 2,500 shares were sold at a weighted average price of $20.5342, with individual prices ranging from $20.265 to $20.825.
- The sales were executed to meet charitable commitments of the Reporting Person in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC.
- Following these transactions, Randall K. Fields directly owns 3,683,955 shares of common stock.
- He also indirectly owns shares through various entities, including RK Fields Charitable 2022, LLC (304,500 shares), Riverview Financial Corp. (615,260 common stock shares and 531,432 Series B Preferred Stock shares), his spouse (30,667 common stock shares and 12,322 Series B Preferred Stock shares), and Fields Management, Inc. (333,643 shares).
Sentiment
Score: 5
Explanation: The sentiment is neutral. The stock sales are for charitable purposes and executed under a pre-arranged plan, mitigating potential negative interpretations. However, any insider selling can create uncertainty.
Positives
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.
- The disclosure provides transparency regarding the CEO's transactions and holdings.
Negatives
- The CEO selling shares, even for charitable purposes, could be perceived negatively by some investors.
Risks
- Continued sales by the CEO could put downward pressure on the stock price.
- Investor sentiment could be negatively impacted if the market interprets the sales as a lack of confidence in the company's future prospects.
Industry Context
Sales by executives are a common occurrence, and the use of a 10b5-1 plan is a standard practice to avoid insider trading concerns. The impact on ReposiTrak will depend on the overall market sentiment and the company's performance.
Comparison to Industry Standards
- Executive stock sales are a regular occurrence in publicly traded companies.
- Companies like Walmart, Amazon, and Target often see similar filings from their executives.
- The use of Rule 10b5-1 trading plans is a common practice among executives to manage their stock sales in a compliant manner.
Stakeholder Impact
- Shareholders may react to the news of the CEO selling shares, although the pre-arranged plan should alleviate concerns.
- The impact on employees, customers, suppliers, and creditors is likely minimal, as the transaction is related to the CEO's personal financial planning.
Key Dates
| Date | Description |
|---|---|
| 02/10/2025 | Sale of 5,000 shares of common stock at a weighted average price of $20.8466. |
| 02/11/2025 | Sale of 2,500 shares of common stock at a weighted average price of $20.5342. |
Keywords
ReposiTrak, Randall Fields, stock sale, Form 4, insider trading, Rule 10b5-1, charitable contributions, TRAK
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.